Ratings by Credit Suisse (Katie Tryhane)
Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
9/10/2021 | Danaher | DHR | Maintain | Outperform (N/A) |
|
Details | ||
8/17/2021 | Sophia Genetics SA | SOPH | New Coverage | Outperform (N/A) |
18.00 (4.96) |
-72.44% | Details | |
8/13/2021 | IDEXX Laboratories | IDXX | Maintain | Outperform (N/A) |
|
Details | ||
8/11/2021 | Maravai LifeScience Holdings Inc. | MRVI | Maintain | Outperform (N/A) |
|
Details | ||
8/10/2021 | Fulgent Genetics | FLGT | Maintain | Underperform (N/A) |
|
Details | ||
8/10/2021 | Syneos | SYNH | Maintain | Outperform (N/A) |
|
Details | ||
8/9/2021 | Zoetis Inc. | ZTS | Maintain | Outperform (N/A) |
|
Details | ||
8/5/2021 | Zoetis Inc. | ZTS | New Coverage | Outperform (N/A) |
204.10 (146.50) |
-28.22% | Details | |
8/5/2021 | Thermo Fisher Scientific | TMO | New Coverage | Outperform (N/A) |
536.99 (544.78) |
1.45% | Details | |
8/5/2021 | Syneos | SYNH | New Coverage | Outperform (N/A) |
88.10 (42.98) |
-51.21% | Details | |
8/5/2021 | PPD Inc. | PPD | New Coverage | Neutral (N/A) |
46.32 (47.30) |
2.12% | Details | |
8/5/2021 | Phibro Animal Health Corp. | PAHC | New Coverage | Neutral (N/A) |
24.56 (13.30) |
-45.85% | Details | |
8/5/2021 | PetMed Express | PETS | New Coverage | Underperform (N/A) |
30.00 (4.11) |
-86.3% | Details | |
8/5/2021 | Ortho Clinical Diagnostics | OCDX | New Coverage | Outperform (N/A) |
21.62 (17.63) |
-18.46% | Details | |
8/5/2021 | Medpace | MEDP | New Coverage | Outperform (N/A) |
176.64 (372.00) |
110.6% | Details | |
8/5/2021 | Maravai LifeScience Holdings Inc. | MRVI | New Coverage | Outperform (N/A) |
47.72 (7.30) |
-84.7% | Details | |
8/5/2021 | IQVIA Holdings | IQV | New Coverage | Outperform (N/A) |
249.98 (228.09) |
-8.76% | Details | |
8/5/2021 | IDEXX Laboratories | IDXX | New Coverage | Outperform (N/A) |
695.67 (476.35) |
-31.53% | Details | |
8/5/2021 | ICON plc | ICLR | New Coverage | Outperform (N/A) |
244.08 (288.23) |
18.09% | Details | |
8/5/2021 | Fulgent Genetics | FLGT | New Coverage | Underperform (N/A) |
100.46 (20.36) |
-79.73% | Details | |
8/5/2021 | Elanco Animal Health | ELAN | New Coverage | Outperform (N/A) |
36.72 (12.95) |
-64.73% | Details | |
8/5/2021 | Danaher | DHR | New Coverage | Outperform (N/A) |
302.33 (235.51) |
-22.1% | Details | |
8/5/2021 | Covetrus | CVET | New Coverage | Neutral (N/A) |
24.69 (20.99) |
-14.99% | Details | |
8/5/2021 | Chewy Inc. | CHWY | New Coverage | Outperform (N/A) |
86.75 (16.15) |
-81.38% | Details | |
8/5/2021 | Charles River Labs | CRL | New Coverage | Neutral (N/A) |
411.24 (226.78) |
-44.85% | Details | |
8/5/2021 | Certara Inc. | CERT | New Coverage | Neutral (N/A) |
26.31 (15.93) |
-39.45% | Details | |
8/5/2021 | Centogene NV | CNTG | New Coverage | Outperform (N/A) |
11.39 (0.46) |
-95.96% | Details | |
8/5/2021 | Avantor Inc. | AVTR | New Coverage | Outperform (N/A) |
37.80 (24.10) |
-36.24% | Details |